The British Pharmacological Society has joined many other leading organisations from across the scientific community in signing a letter to Sir Jeremy Heywood, Cabinet Secretary and Head of the Civil…
The British Pharmacological Society is one of a dozen signatories of a letter to the Cabinet Secretary asking for clarification of the application of election 'purdah' rules to…
Use of fluoxetine – the most commonly prescribed antidepressant – during pregnancy is linked with a slightly increased risk of malformations in infants, according to a recent analysis of…
The Society provided a written response to the Department for Business, Energy and Industrial Strategy’s Industrial Strategy Green Paper. The Green Paper sets out proposals on how to…
The Society provided a written response to the Higher Education Funding Council for England (HEFCE)’s Research Excellence Framework (REF). The consultation set out proposals on how to…
The British Pharmacological Society and the Royal College of Physicians and Surgeons of Canada (RCPSC) today announced an ambitious new collaboration to support safer prescribing by doctors in…
In recent months British Pharmacological Society members have been encouraging us to do more to protect and promote pharmacology – whether in academic, industrial or clinical settings – and to…
We have certainly kicked off 2017 with a bang here at the Society and this issue brings together the latest developments and changes driven by you! Jono’s article shares what is currently being…
At our recent annual meeting, Pharmacology 2016, we welcomed 1,070 guests from 44 countries to the Queen Elizabeth II Conference Centre in Central London.The Society hosted are record number of 16…
The Finance Committee at the British Pharmacological Society may seem a little mysterious in comparison with those committees more directly relevant to members’ areas of primary interest and…
